Search results for "Myocardial infarction"
Advice on monoclonal antibodies; new data on long-term COVID-19 symptoms, vaccine efficacy
The NIH offered guidance on prioritization when monoclonal antibodies can't be given to all eligible patients. Two studies looked at patients with persistent COVID-19 symptoms, and other research confirmed the safety and effectiveness of the vaccines, even with the delta variant.
https://immattersacp.org/weekly/archives/2021/09/14/2.htm
14 Sep 2021
PDE5 inhibitors didn't increase cardiovascular events in men on nitrates for heart disease
A Danish study also found that more men with ischemic heart disease are taking both nitrates and a phosphodiesterase type 5 (PDE5) inhibitor, with the prescription rate increasing 20-fold from 2000 to 2018.
https://immattersacp.org/weekly/archives/2022/04/19/1.htm
19 Apr 2022
Screen cardiovascular disease patients for sleep apnea, AHA recommends
The prevalence of obstructive sleep apnea is as high as 40% to 80% in patients with hypertension, heart failure, coronary artery disease, pulmonary hypertension, atrial fibrillation, or stroke, according to a new scientific statement from the American Heart Association (AHA).
https://immattersacp.org/weekly/archives/2021/06/29/2.htm
29 Jun 2021
Latest research shows impact of COVID-19 on other health care
Hospitalizations for stroke and myocardial infarction, ED visits, cancer diagnoses, and trials for conditions other than COVID-19 all dropped during the pandemic, recent studies show.
https://immattersacp.org/weekly/archives/2020/08/11/1.htm
11 Aug 2020
Scientific statement reviews cardiovascular risks, prevention, and treatment in patients with HIV
Even when adequately controlled, HIV is associated with increased cardiovascular risk, said a recent scientific statement from the American Heart Association, which offered advice on risk assessment and preventive treatment.
https://immattersacp.org/weekly/archives/2019/06/11/2.htm
11 Jun 2019
Acute MI may be undertreated in patients with mild cognitive impairment
Rates of cardiac catheterization, coronary revascularization, and cardiac rehabilitation after hospitalization for acute myocardial infarction (MI) were compared in older patients with preexisting mild cognitive impairment versus those without impaired cognition.
https://immattersacp.org/weekly/archives/2019/08/20/4.htm
20 Aug 2019
High-dose flu vaccine may not be more effective than standard dose in patients with high-risk cardiovascular disease
An industry-funded randomized trial in the U.S. and Canada found no significant difference between a high-dose group versus a standard-dose group in the time to first occurrence of all-cause death or cardiopulmonary hospitalization during three flu seasons.
https://immattersacp.org/weekly/archives/2020/12/15/5.htm
15 Dec 2020
Cardiovascular events similar, adverse effects worse with chlorthalidone compared to hydrochlorothiazide
Chlorthalidone was associated with a significantly higher risk of hypokalemia, hyponatremia, acute renal failure, chronic kidney disease, type 2 diabetes, and abnormal weight gain.
https://immattersacp.org/weekly/archives/2020/02/25/2.htm
25 Feb 2020
Dual therapy for afib after PCI may reduce bleeding risk better than triple therapy
Researchers reviewed four randomized controlled trials of 7,953 patients that compared the effects of dual versus triple therapy on bleeding, mortality, and ischemic events after percutaneous coronary intervention (PCI).
https://immattersacp.org/weekly/archives/2020/03/17/4.htm
17 Mar 2020
Lack of access to PCSK9 inhibitors associated with cardiovascular events
Risk for myocardial infarction, unstable angina, acute ischemic heart disease, ischemic stroke, percutaneous coronary intervention, coronary artery bypass graft, and cardiac arrest was higher in patients whose prescription for a PCSK9 inhibitor was denied or abandoned.
https://immattersacp.org/weekly/archives/2019/07/30/2.htm
30 Jul 2019